Aaron (Yang) Gu

Practice Areas

· Life sciences and healthcare

· Corporate compliance

· Foreign investment

· Mergers and acquisitions

· General corporate

Career

Mr. Gu practiced law with Covington & Burling LLP in Shanghai, Washington D.C., and New York for approximately eight years before joining Han Kun Law Offices in 2022. Prior to Covington, Mr. Gu also interned and worked for many years in the New York office of Jun He Law Offices and the Shanghai office of Advokatfirman Vinge KB.

Mr. Gu focuses on corporate, regulatory compliance, and transactional services for life sciences, biopharmaceutical, medical and healthcare industries, including biosecurity and human genetic resource issues, clinical trial matters, product marketing authorizations, GxP compliance, Spin off-NewCo transactions, drug licensing and collaboration, as well as regulatory issues involved in venture capital and private equity investments, mergers and acquisitions, and foreign and outbound investments in the life sciences industries. Mr. Gu also provides advocacy advice on draft laws and regulations released by the NMPA and other Chinese governmental authorities. Specifically, Mr. Gu's services cover a full range of products including drugs (biologics and chemical drugs), medical devices, IVDs, cosmetics, general foods, special foods (health foods, foods for special medical purposes, and infant formulas), animal drugs, animal foods, etc.

Mr. Gu has extensive experience representing various types of companies in the life sciences industry, including renowned multinational pharmaceutical companies, leading Chinese innovative drug and biotechnology companies, and top domestic and international investment institutions. Mr. Gu has co-authored the China section of Chambers Life Sciences Global Practice Guide (2022-2025) and other publications. His outstanding and professional services have earned him numerous accolades from prestigious institutions such as Chambers and Partners, The Legal 500, China Business Law Journal, Lexpress, LegalOne, Lex Falcon Global Awards, Asian Legal Business (ALB), Legalband and Mondaq. Furthermore, Mr. Gu has been frequently interviewed by 36Kr, Blue View, Caixin, China Business Network, Dutch Financial Daily, Economic Observer, Faxian Magazine, Financial Times, Healthcare Executive, International Pharmaceutical News for China, Jiemian, Southern Weekly, Thomson Reuters and other media (in alphabetical order).

Professional Memberships

Member of the PRC Bar

Member of the New York State Bar

Publications

The China chapter of Editions 7, 8, 9, and 10 (2019-2022) of The Life Sciences Law Review;

The China chapter of Editions 6, 7 and 8 (2022-2024) of Lexology In-Depth: Healthcare Law (formerly known as The Healthcare Law Review);

The China section of Chambers Life Sciences Global Practice Guide (2022-2025);

The China section of Chambers Healthcare: Medical Devices Global Practice Guide (2023-2024);

The China chapter of The Legal 500’s Country Comparative Guides for Life Sciences (2024).

Personal

Mr. Gu holds several professional positions, including an Ethics Committee Member of Digital & Intelligent Medical Ethics Review Panel of Shanghai Ethics Committee for Clinical Research, a Full Member of the American Scientific Research Honor Society (Sigma Xi), a Member of the Professional Committee of Pharmaceutical and Healthcare Affairs of Shanghai Bar Association, the Special Consultant of the Science and Technology Innovation Board of the Pujiang Capital Market Training Base, a Member of Investment and Financing Committee of Clinical Trial Industry Technology Innovation Strategic Alliance and a Member of the Board of Supervisors of Shanghai Baoshan Synthetic Biology Transformation Institute. He also serves as the Vice President of the NYU Alumni Club in Shanghai and the Practical Mentor of KoGuan School of Law of Shanghai Jiao Tong University.

Awards